Immunofluorescence Analysis of T-cell Responses in Health and Disease

Overview

Journal J Clin Immunol

Publisher Springer

Specialty Allergy & Immunology

Date 2001 Feb 24

PMID 11202228

Citations 14

Authors

H T Maecker

V C Maino

L J Picker

Affiliations

Soon will be listed here.

Abstract

The use of flow cytometry to study the functional responses of T cells by immunofluorescent staining for intracellular cytokines and other markers is a growing field of clinical interest. In this article, we describe methods for the rapid evaluation of T-cell responses to mitogens and specific antigens and explore how these assays might be valuable in various clinical settings.

Citing Articles

Diagnostic performance of cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in kidney transplantation: A PRISMA-compliant article.

Ruan Y, Guo W, Liang S, Xu Z, Niu T Medicine (Baltimore). 2019; 98(16):e15228.

PMID: 31008952 PMC: 6494277. DOI: 10.1097/MD.0000000000015228.

Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot Assay but Not CMV QuantiFERON Assay Is a Novel Biomarker To Determine Risk of Congenital CMV Infection in Pregnant Women.

Forner G, Saldan A, Mengoli C, Gussetti N, Palu G, Abate D J Clin Microbiol. 2016; 54(8):2149-54.

PMID: 27280418 PMC: 4963489. DOI: 10.1128/JCM.00561-16.

Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studies.

Garcia-Sicilia J, Aristegui J, Omenaca F, Carmona A, Tejedor J, Merino J Hum Vaccin Immunother. 2015; 11(10):2359-69.

PMID: 26176592 PMC: 4635840. DOI: 10.1080/21645515.2015.1063754.

Phase II, randomized, open, controlled study of AS03-adjuvanted H5N1 pre-pandemic influenza vaccine in children aged 3 to 9 years: follow-up of safety and immunogenicity persistence at 24 months post-vaccination.

Diez-Domingo J, Baldo J, Planelles-Catarino M, Garces-Sanchez M, Ubeda I, Jubert-Rosich A Influenza Other Respir Viruses. 2015; 9(2):68-77.

PMID: 25652873 PMC: 4353319. DOI: 10.1111/irv.12295.

Superior antigen-specific CD4+ T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and older.

Couch R, Bayas J, Caso C, Mbawuike I, Nunez Lopez C, Claeys C BMC Infect Dis. 2014; 14:425.

PMID: 25078387 PMC: 4138369. DOI: 10.1186/1471-2334-14-425.

References

Picker L, Maino V . The CD4(+) T cell response to HIV-1. Curr Opin Immunol. 2000; 12(4):381-6. DOI: 10.1016/s0952-7915(00)00104-7. View

Rinaldo Jr C, Huang X, Fan Z, Margolick J, Borowski L, Hoji A . Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency. J Virol. 2001; 74(9):4127-38. PMC: 111927. DOI: 10.1128/jvi.74.9.4127-4138.2000. View

Nomura L, Walker J, Maecker H . Optimization of whole blood antigen-specific cytokine assays for CD4(+) T cells. Cytometry. 2000; 40(1):60-8. DOI: 10.1002/(sici)1097-0320(20000501)40:1<60::aid-cyto8>3.0.co;2-j. View

Dutton R, Swain S, Bradley L . The generation and maintenance of memory T and B cells. Immunol Today. 1999; 20(7):291-3. DOI: 10.1016/s0167-5699(98)01415-7. View

Kalams S, Goulder P, Shea A, Jones N, Trocha A, Ogg G . Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy. J Virol. 1999; 73(8):6721-8. PMC: 112757. DOI: 10.1128/JVI.73.8.6721-6728.1999. View

Kern F, Faulhaber N, Khatamzas E, Frommel C, Ewert R, Prosch S . Measurement of anti-human cytomegalovirus T cell reactivity in transplant recipients and its potential clinical use: a mini-review. Intervirology. 2000; 42(5-6):322-4. DOI: 10.1159/000053967. View

Kern F, Surel I, Brock C, Freistedt B, Radtke H, Scheffold A . T-cell epitope mapping by flow cytometry. Nat Med. 1998; 4(8):975-8. DOI: 10.1038/nm0898-975. View

Badley A, McElhinny J, Leibson P, Lynch D, Alderson M, Paya C . Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J Virol. 1996; 70(1):199-206. PMC: 189805. DOI: 10.1128/JVI.70.1.199-206.1996. View

Zajac A, Blattman J, Sourdive D, Suresh M, Altman J, Ahmed R . Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med. 1998; 188(12):2205-13. PMC: 2212420. DOI: 10.1084/jem.188.12.2205. View

10.

Sander B, Hoiden I, Andersson U, Moller E, Abrams J . Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. Cytokine detection by immunoassay and intracellular immunostaining. J Immunol Methods. 1993; 166(2):201-14. DOI: 10.1016/0022-1759(93)90361-a. View

11.

Rosenberg E, Billingsley J, Caliendo A, Boswell S, Sax P, Kalams S . Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science. 1997; 278(5342):1447-50. DOI: 10.1126/science.278.5342.1447. View

12.

Gray C, Lawrence J, Schapiro J, Altman J, Winters M, Crompton M . Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART). J Immunol. 1999; 162(3):1780-8. View

13.

Weynants V, Walravens K, Didembourg C, Flanagan P, Godfroid J, Letesson J . Quantitative assessment by flow cytometry of T-lymphocytes producing antigen-specific gamma-interferon in Brucella immune cattle. Vet Immunol Immunopathol. 1999; 66(3-4):309-20. DOI: 10.1016/s0165-2427(98)00205-0. View

14.

Czerkinsky C, Nilsson L, Nygren H, OUCHTERLONY O, Tarkowski A . A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods. 1983; 65(1-2):109-21. DOI: 10.1016/0022-1759(83)90308-3. View

15.

Orlikowsky T, Wang Z, Dudhane A, Horowitz H, Riethmuller G, Hoffmann M . Cytotoxic monocytes in the blood of HIV type 1-infected subjects destroy targeted T cells in a CD95-dependent fashion. AIDS Res Hum Retroviruses. 1997; 13(11):953-60. DOI: 10.1089/aid.1997.13.953. View

16.

Swain S, Hu H, Huston G . Class II-independent generation of CD4 memory T cells from effectors. Science. 1999; 286(5443):1381-3. DOI: 10.1126/science.286.5443.1381. View

17.

Oxenius A, Price D, Easterbrook P, OCallaghan C, Kelleher A, Whelan J . Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes. Proc Natl Acad Sci U S A. 2000; 97(7):3382-7. PMC: 16248. DOI: 10.1073/pnas.97.7.3382. View

18.

Vingerhoets J, Dohlsten M, Penne G, Colebunders R, Sansom D, Bosmans E . Superantigen activation of CD4+ and CD8+T cells from HIV-infected subjects: role of costimulatory molecules and antigen-presenting cells (APC). Clin Exp Immunol. 1998; 111(1):12-9. PMC: 1904857. DOI: 10.1046/j.1365-2249.1998.00465.x. View

19.

Karanikas V, Lodding J, Maino V, McKenzie I . Flow cytometric measurement of intracellular cytokines detects immune responses in MUC1 immunotherapy. Clin Cancer Res. 2000; 6(3):829-37. View

20.

Suni M, Picker L, Maino V . Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry. J Immunol Methods. 1998; 212(1):89-98. DOI: 10.1016/s0022-1759(98)00004-0. View